Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | JAK2 | O60674 | 20/20 | 0.59 |
| ▸ | JAK1 | P23458 | 20/20 | 0.59 |
| ▸ | TYK2 | P29597 | 3/20 | 0.52 |
| ▸ | JAK3 | P52333 | 3/20 | 0.52 |
| ▸ | AURKA | O14965 | 1/20 | 0.51 |
| ▸ | PRKCA | P17252 | 1/20 | 0.51 |
| ▸ | KDR | P35968 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2275731 | 1.00 | JAK2 (0.59) | JAK2JAK1TYK2JAK3AURKA | |
| SCHEMBL2275734 | 1.00 | JAK2 (0.59) | JAK2JAK1TYK2JAK3AURKA | |
| SCHEMBL27432005 | 0.90 | JAK2 (0.61) | JAK2JAK1TYK2JAK3AURKA | |
| SCHEMBL2280497 | 0.87 | JAK2 (0.66) | JAK2JAK1TYK2JAK3AURKA | |
| SCHEMBL13398229 | 0.83 | JAK2 (0.62) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL27433394 | 0.81 | JAK1 (0.60) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL16470096 | 0.81 | MAP2K1 (0.53) | — | |
| SCHEMBL16470094 | 0.81 | MAP2K1 (0.53) | — | |
| SCHEMBL25240987 | 0.80 | JAK1 (0.66) | JAK2JAK1TYK2JAK3 | |
| SCHEMBL29460632 | 0.80 | JAK1 (0.66) | JAK2JAK1TYK2JAK3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2523957-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. Hoffmann-La Roche AG (CH) | 2012-11-21 | — | — | EP | disclosed |
| WO-2011086053-A1 | TRICYCLIC HETEROCYCLIC COMPOUNDS, COMPOSITIONS AND METHODS OF USE THEREOF | F. HOFFMANN-LA ROCHE AG (CH) | 2011-07-21 | — | — | WO | disclosed |